Sanomedics International Holdings Inc. (SIMH) Fina
Post# of 250675
Posted On: 11/17/2014 3:24:08 AM
Sanomedics International Holdings Inc. (SIMH) Financials Nov 14, 2014, 4:00 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Sanomedics International Holdings Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 31,018 90,208 98,889 95,376 263,745
Cost of Goods Sold (COGS) incl. D&A 23,888 75,294 184,543 66,493 68,617
COGS excluding D&A 23,656 73,743 171,961 57,215 59,149
Depreciation & Amortization Expense 232 1,551 12,582 9,278 9,468
Depreciation 232 1,551 - 4,301 4,488
Amortization of Intangibles 0 0 - 4,977 4,980
Gross Income 7,130 14,914 (85,654) 28,883 195,128
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.37M 2.37M 3.05M 1.57M 2.02M
Research & Development 446,652 243,188 241,117 152,825 111,500
Other SG&A 925,492 2.13M 2.8M 1.41M 1.91M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 1.89M
EBIT after Unusual Expense 0 0 0 0 (1.89M)
Non Operating Income/Expense 0 0 0 13,614 0
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 12,138 95,273 177,146 250,069 602,089
Gross Interest Expense 12,138 95,273 177,146 250,069 602,089
Interest Capitalized 0 0 0 0 0
Pretax Income (1.38M) (2.45M) (3.31M) (1.77M) (4.31M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (1.38M) (2.45M) (3.31M) (1.77M) (4.31M)
Minority Interest Expense 0 0 0 0 0
Net Income (1.38M) (2.45M) (3.31M) (1.77M) (4.31M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 - 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.38M) (2.45M) (3.31M) (1.77M) (4.31M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.38M) (2.45M) (3.31M) (1.77M) (4.31M)
EPS (Basic) (1.50) (1.80) (2.40) (1.20) (2.65)
Basic Shares Outstanding 904,277 1.33M 1.37M 1.51M 1.63M
EPS (Diluted) (1.50) (1.80) (2.40) (1.20) (2.65)
Diluted Shares Outstanding 904,277 1.33M 1.37M 1.51M 1.63M
EBITDA (1.36M) (2.36M) (3.12M) (1.53M) (1.81M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Sanomedics International Holdings Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 31,018 90,208 98,889 95,376 263,745
Cost of Goods Sold (COGS) incl. D&A 23,888 75,294 184,543 66,493 68,617
COGS excluding D&A 23,656 73,743 171,961 57,215 59,149
Depreciation & Amortization Expense 232 1,551 12,582 9,278 9,468
Depreciation 232 1,551 - 4,301 4,488
Amortization of Intangibles 0 0 - 4,977 4,980
Gross Income 7,130 14,914 (85,654) 28,883 195,128
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.37M 2.37M 3.05M 1.57M 2.02M
Research & Development 446,652 243,188 241,117 152,825 111,500
Other SG&A 925,492 2.13M 2.8M 1.41M 1.91M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 1.89M
EBIT after Unusual Expense 0 0 0 0 (1.89M)
Non Operating Income/Expense 0 0 0 13,614 0
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 12,138 95,273 177,146 250,069 602,089
Gross Interest Expense 12,138 95,273 177,146 250,069 602,089
Interest Capitalized 0 0 0 0 0
Pretax Income (1.38M) (2.45M) (3.31M) (1.77M) (4.31M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (1.38M) (2.45M) (3.31M) (1.77M) (4.31M)
Minority Interest Expense 0 0 0 0 0
Net Income (1.38M) (2.45M) (3.31M) (1.77M) (4.31M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 - 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.38M) (2.45M) (3.31M) (1.77M) (4.31M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.38M) (2.45M) (3.31M) (1.77M) (4.31M)
EPS (Basic) (1.50) (1.80) (2.40) (1.20) (2.65)
Basic Shares Outstanding 904,277 1.33M 1.37M 1.51M 1.63M
EPS (Diluted) (1.50) (1.80) (2.40) (1.20) (2.65)
Diluted Shares Outstanding 904,277 1.33M 1.37M 1.51M 1.63M
EBITDA (1.36M) (2.36M) (3.12M) (1.53M) (1.81M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)